# DRTECH

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drtech

- Industry: Medical Devices & Equipment
- Headquarters: South Korea
- Website: www.drtech.co.kr/
- Total disclosed funding: $4.3M
- Latest round: Series B (Jun 18, 2012)
- Investors on record: 2

## About

DRTECH, located in Gyeonggi-do, South Korea, specializes in advanced medical imaging solutions, delivering innovative products that improve diagnostic accuracy while minimizing radiation exposure in healthcare environments.Founded in 2003 in Gyeonggi-do, South Korea, DRTECH focuses on developing advanced medical imaging technologies. The company has expanded its operations and secured significant investments, including a Series B funding round in April 2015, which raised KRW 5.0 billion from Mirae Asset Venture Investment and SL Investment. This funding has allowed DRTECH to solidify its position in medical imaging, with a total amount raised of KRW 5.0 billion from two funding rounds.DRTECH specializes in advanced medical imaging solutions, prominently featuring its core offerings such as the Lowest Dose Mobile C-arm, Premium Digital Mammography system, and Digital X-ray Detector systems. These products are designed to enhance diagnostic accuracy while minimizing radiation exposure, addressing critical needs within healthcare settings. The C-arm equipment provides high-quality imaging, facilitating surgical procedures and radiological examinations with reduced fatigue for healthcare professionals. The Premium Digital Mammography system enhances the clarity and detail of breast imaging, improving diagnostic outcomes. These products are primarily marketed to hospitals, diagnostic imaging centers, and specialty clinics across multiple geographical regions, including North America, Europe, and Asia, catering to a diverse client base of healthcare providers and institutions.DRTECH’s revenue model is structured around direct sales of its imaging equipment and systems to healthcare facilities and medical institutions. Transactions typically occur through one-time purchases, with potential for ongoing maintenance contracts and service agreements that ensure the longevity and efficiency of their products. The company’s flagship offerings, such as the Lowest Dose Mobile C-arm and Premium Digital Mammography system, are integral to its revenue generation strategy. While specific pricing plans for these products are not disclosed, the business model supports significant capital investment from clients seeking long-term solutions in medical imaging. This direct-to-client sales approach solidifies DRTECH's position in the competitive market of medical imaging technology.In April 2015, DRTECH raised KRW 8.2 billion in an IPO, selling 4.1 million shares at KRW 2,000 per share on the KOSDAQ. The recent funding will support the development of new imaging technologies and expansion into new markets, particularly targeting North America and Europe by 2025. DRTECH plans to launch additional imaging products aimed at enhancing diagnostic capabilities within the next two years.

## Funding rounds

- Series B, Jun 18, 2012, $4.3M — SL Investment, Mirae Asset Venture Investment

## Investors

- SL Investment (https://capitalatlas.ai/funds/sl-investment) — Series B
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series B